Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
IsraelIPO:
11 May 2015Website:
http://www.scinai.comNext earnings report:
03 July 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:55:34 GMTDividend
Analysts recommendations
Institutional Ownership
SCNI Latest News
JERUSALEM , July 2, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today published its financial results for the quarter ended March 31, 2024, and provided a business update.
JERUSALEM , June 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) (the "Company"), a biotechnology company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today announced that it has received a non-binding Letter of Intent ("LoI") from the European Investment Bank (the "EIB").
What type of business is Scinai Immunotherapeutics?
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
What sector is Scinai Immunotherapeutics in?
Scinai Immunotherapeutics is in the Healthcare sector
What industry is Scinai Immunotherapeutics in?
Scinai Immunotherapeutics is in the Biotechnology industry
What country is Scinai Immunotherapeutics from?
Scinai Immunotherapeutics is headquartered in Israel
When did Scinai Immunotherapeutics go public?
Scinai Immunotherapeutics initial public offering (IPO) was on 11 May 2015
What is Scinai Immunotherapeutics website?
https://www.scinai.com
Is Scinai Immunotherapeutics in the S&P 500?
No, Scinai Immunotherapeutics is not included in the S&P 500 index
Is Scinai Immunotherapeutics in the NASDAQ 100?
No, Scinai Immunotherapeutics is not included in the NASDAQ 100 index
Is Scinai Immunotherapeutics in the Dow Jones?
No, Scinai Immunotherapeutics is not included in the Dow Jones index
When does Scinai Immunotherapeutics report earnings?
The next expected earnings date for Scinai Immunotherapeutics is 03 July 2024